Edgewise Therapeutics, Inc. EWTX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s accounts payable?
- Edgewise Therapeutics, Inc. (EWTX) reported accounts payable of $7.29M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s accounts payable changed year-over-year?
- Edgewise Therapeutics, Inc.'s accounts payable decreased by 17.0% year-over-year, from $8.79M to $7.29M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s accounts payable?
- Over 4 years (2021 to 2025), Edgewise Therapeutics, Inc.'s accounts payable has grown at a 29.0% compound annual growth rate (CAGR), from $10.57M to $29.27M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.